Quest Stock Based Compensation from 2010 to 2025

DGX Stock

USD 166.14 0.14 0.08%

Quest Diagnostics Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 64.7 M in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals

Stock Based Compensation

First Reported

1997-03-31

Previous Quarter

19 M

Current Value

27 M

Quarterly Volatility

13.2 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Quest Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Quest Diagnostics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 274.7 M, Interest Expense of 237.3 M or Selling General Administrative of 1.5 B, as well as many indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.0208 or PTB Ratio of 2.99. Quest financial statements analysis is a perfect complement when working with Quest Diagnostics Valuation or Volatility modules.

Check out the analysis of Quest Diagnostics Correlation against competitors.

Latest Quest Diagnostics' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Quest Diagnostics Incorporated over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Quest Diagnostics' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Quest Diagnostics' overall financial position and show how it may be relating to other accounts over time.

Stock Based Compensation

10 Years Trend

Very volatile

Compare to Others All Fundamentals

Stock Based Compensation

Timeline

Quest Stock Based Compensation Regression Statistics

	Arithmetic Mean	73,366,536
	Geometric Mean	68,288,861
	Coefficient Of Variation	42.94
	Mean Deviation	19,554,281
	Median	71,900,000
	Standard Deviation	31,504,317
	Sample Variance	992.5T
	Range	145M
	R-Value	(0.07)
	Mean Square Error	1058.1T
	R-Squared	0
	Significance	0.80
	Slope	(466,223)
	Total Sum of Squares	14887.8T

Quest Stock Based Compensation History

	2025	64.7 M
	2024	88 M
	2022	77 M
	2020	97 M
	2019	56 M
	2018	61 M
	2017	79 M

Other Fundumenentals of Quest Diagnostics

Stock Based Compensation To Revenue

Quest Diagnostics Stock Based Compensation component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Intangible Assets	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	0.66	0.86	0.29	0.94	0.99	0.87	0.39	0.79	0.87	0.96	0.66	0.97	-0.77	0.51	0.35	0.83	0.28	0.18	-0.14	0.31	0.64	0.42	-0.05
Total Stockholder Equity	0.99		0.61	0.87	0.23	0.96	0.95	0.88	0.3	0.76	0.82	0.92	0.65	0.94	-0.8	0.5	0.43	0.82	0.31	0.26	-0.24	0.33	0.6	0.48	-0.01
Net Debt	0.66	0.61		0.84	0.79	0.56	0.7	0.48	0.68	0.59	0.73	0.74	0.82	0.76	-0.61	0.51	0.0	0.73	0.38	-0.14	0.3	0.11	0.75	-0.03	-0.72
Retained Earnings	0.86	0.87	0.84		0.52	0.82	0.82	0.74	0.48	0.67	0.74	0.82	0.79	0.87	-0.89	0.52	0.37	0.82	0.53	0.24	-0.04	0.33	0.69	0.3	-0.41
Accounts Payable	0.29	0.23	0.79	0.52		0.25	0.33	0.25	0.55	0.1	0.51	0.38	0.74	0.35	-0.18	0.47	0.11	0.58	0.41	-0.29	0.41	0.13	0.81	-0.04	-0.94
Net Receivables	0.94	0.96	0.56	0.82	0.25		0.89	0.93	0.3	0.68	0.75	0.83	0.66	0.87	-0.7	0.53	0.5	0.78	0.27	0.17	-0.31	0.46	0.61	0.65	-0.03
Total Liab	0.99	0.95	0.7	0.82	0.33	0.89		0.83	0.47	0.8	0.9	0.97	0.65	0.97	-0.72	0.5	0.27	0.83	0.25	0.09	-0.04	0.27	0.66	0.36	-0.08
Total Current Assets	0.87	0.88	0.48	0.74	0.25	0.93	0.83		0.38	0.54	0.64	0.74	0.62	0.74	-0.6	0.63	0.65	0.76	0.3	0.17	-0.16	0.7	0.68	0.77	-0.04
Short Term Debt	0.39	0.3	0.68	0.48	0.55	0.3	0.47	0.38		0.26	0.52	0.39	0.5	0.42	-0.35	0.3	0.0	0.45	0.39	-0.12	0.7	0.38	0.62	-0.03	-0.52
Common Stock	0.79	0.76	0.59	0.67	0.1	0.68	0.8	0.54	0.26		0.68	0.84	0.28	0.86	-0.72	0.28	-0.15	0.44	0.21	0.16	-0.09	0.04	0.21	0.08	0.02
Intangible Assets	0.87	0.82	0.73	0.74	0.51	0.75	0.9	0.64	0.52	0.68		0.91	0.63	0.89	-0.61	0.35	0.13	0.81	0.37	0.07	0.11	0.08	0.71	0.13	-0.26
Long Term Debt	0.96	0.92	0.74	0.82	0.38	0.83	0.97	0.74	0.39	0.84	0.91		0.63	0.98	-0.73	0.46	0.18	0.83	0.29	0.13	-0.07	0.15	0.63	0.24	-0.15
Property Plant Equipment	0.66	0.65	0.82	0.79	0.74	0.66	0.65	0.62	0.5	0.28	0.63	0.63		0.67	-0.46	0.66	0.38	0.84	0.19	-0.24	0.06	0.25	0.87	0.28	-0.62
Good Will	0.97	0.94	0.76	0.87	0.35	0.87	0.97	0.74	0.42	0.86	0.89	0.98	0.67		-0.79	0.45	0.16	0.79	0.26	0.1	-0.08	0.13	0.6	0.24	-0.15
Treasury Stock	-0.77	-0.8	-0.61	-0.89	-0.18	-0.7	-0.72	-0.6	-0.35	-0.72	-0.61	-0.73	-0.46	-0.79		-0.24	-0.3	-0.62	-0.6	-0.53	0.13	-0.25	-0.36	-0.2	0.1
Current Deferred Revenue	0.51	0.5	0.51	0.52	0.47	0.53	0.5	0.63	0.3	0.28	0.35	0.46	0.66	0.45	-0.24		0.43	0.54	0.14	-0.25	0.17	0.46	0.68	0.41	-0.39
Net Tangible Assets	0.35	0.43	0.0	0.37	0.11	0.5	0.27	0.65	0.0	-0.15	0.13	0.18	0.38	0.16	-0.3	0.43		0.51	0.36	0.39	-0.3	0.69	0.49	0.76	0.03
Long Term Debt Total	0.83	0.82	0.73	0.82	0.58	0.78	0.83	0.76	0.45	0.44	0.81	0.83	0.84	0.79	-0.62	0.54	0.51		0.39	0.15	-0.09	0.37	0.84	0.4	-0.37
Capital Surpluse	0.28	0.31	0.38	0.53	0.41	0.27	0.25	0.3	0.39	0.21	0.37	0.29	0.19	0.26	-0.6	0.14	0.36	0.39		0.65	0.22	0.41	0.37	0.1	-0.4
Long Term Investments	0.18	0.26	-0.14	0.24	-0.29	0.17	0.09	0.17	-0.12	0.16	0.07	0.13	-0.24	0.1	-0.53	-0.25	0.39	0.15	0.65		-0.3	0.27	-0.16	0.17	0.3
Short Long Term Debt	-0.14	-0.24	0.3	-0.04	0.41	-0.31	-0.04	-0.16	0.7	-0.09	0.11	-0.07	0.06	-0.08	0.13	0.17	-0.3	-0.09	0.22	-0.3		0.04	0.3	-0.45	-0.47
Cash And Equivalents	0.31	0.33	0.11	0.33	0.13	0.46	0.27	0.7	0.38	0.04	0.08	0.15	0.25	0.13	-0.25	0.46	0.69	0.37	0.41	0.27	0.04		0.4	0.76	-0.09
Net Invested Capital	0.64	0.6	0.75	0.69	0.81	0.61	0.66	0.68	0.62	0.21	0.71	0.63	0.87	0.6	-0.36	0.68	0.49	0.84	0.37	-0.16	0.3	0.4		0.34	-0.62
Net Working Capital	0.42	0.48	-0.03	0.3	-0.04	0.65	0.36	0.77	-0.03	0.08	0.13	0.24	0.28	0.24	-0.2	0.41	0.76	0.4	0.1	0.17	-0.45	0.76	0.34		0.18
Capital Stock	-0.05	-0.01	-0.72	-0.41	-0.94	-0.03	-0.08	-0.04	-0.52	0.02	-0.26	-0.15	-0.62	-0.15	0.1	-0.39	0.03	-0.37	-0.4	0.3	-0.47	-0.09	-0.62	0.18

Click cells to compare fundamentals

About Quest Diagnostics Financial Statements

Quest Diagnostics investors use historical fundamental indicators, such as Quest Diagnostics' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Quest Diagnostics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Stock Based Compensation	88 M	64.7 M
Stock Based Compensation To Revenue	0.01	0.01

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Quest Stock Based Compensation from 2010 to 2025

Latest Quest Diagnostics' Stock Based Compensation Growth Pattern

Quest Stock Based Compensation Regression Statistics

Quest Stock Based Compensation History

Other Fundumenentals of Quest Diagnostics

Quest Diagnostics Stock Based Compensation component correlations

About Quest Diagnostics Financial Statements

Also Currently Popular

Additional Tools for Quest Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY